NASDAQ:LGVN

Longeveron Stock Predictions

etoro logo Buy LGVN
*Your capital is at risk
$0.80
+0.0400 (+5.26%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

LGVN Prediction Chart

LGVN Predictions History

Latest community submissions for LGVN.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 14, 2024 $3.00 +65.75% $3.19 V 94.04% 1
Jun 13, 2024 $1.72 -5.19% $2.69 X 63.79% 0
Jun 13, 2024 $1.75 -3.24% $2.69 X 65.10% 0
Jun 13, 2024 Bullish $2.69 V 1
Apr 1, 2022 Bullish $15.56 X 1
JS JS Pro
Jan 24, 2022 $5.98 -91.07% $6.70 V 89.25% 0
Jan 24, 2022 Bearish $6.70 V 0
JS JS Pro
Jan 13, 2022 $8.11 -90.79% $8.77 V 92.47% 1
Jan 13, 2022 $30.00 -65.95% $8.77 X 0.00% 0
JS JS Pro
Jan 5, 2022 $10.93 -90.78% $11.86 V 92.16% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LGVN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT LONGEVERON INC.
Longeveron
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE